May DEI Community Call: Promoting Diversity in Clinical Trials

5/1/24 1-2PM ET - Webinars

Historically, clinical trials did not always recruit participants who represented the individuals most affected by a particular disease, condition, or behavior. This has created gaps in our understanding of disease and can impede the quality of health care. Clinicians and researchers should carefully consider the inclusion or exclusion criteria for their clinical trials. In this session, we will discuss the need for inclusion in clinical trials (the why) and hear examples of what HRA member organizations are doing to increase diversity and inclusion in clinical trials, including any guidance that funders can provide to their applicants.


Barbara Bierer, MD
Professor of Medicine, Harvard Medical School
Co-Founder, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard

Patricia Hurley, MSc
Senior Director, Strategic Research Initiatives, American Society of Clinical Oncology

Alice Kuaban, MS
Deputy Director, Scientific Affairs, American Society of Hematology